CTI BIOPHARMA CORP (CTIC)       5.52  -0.11 (-1.95%)

5.52  -0.11 (-1.95%)

US12648L6011 - Common Stock - After market: 5.54 +0.02 (+0.36%)

News Image
5 days ago - CTI BioPharma Corp.

CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that senior leadership will participate in a Fireside Chat at the following investor...

News Image
13 days ago - CTI BioPharma Corp.

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...

News Image
a month ago - CTI BioPharma Corp.

CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will present a corporate overview at the 41st Annual J.P. Morgan Healthcare...

News Image
a month ago - Market News Video

CTIC Crosses Below Key Moving Average Level

News Image
2 months ago - CTI BioPharma Corp.

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...

News Image
2 months ago - CTI BioPharma Corp.

CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation and two poster presentations from the Company's pacritinib program at...

News Image
2 months ago - FinancialNewsMedia.com

Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope

/PRNewswire/ -- The global ovarian cancer market is projected to continue to grow through the coming several years. The formation of mutational cells or...

News Image
2 months ago - FinancialNewsMedia

Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope

EQNX::TICKER_START (OTCQB:BVAXF),(NASDAQ:CTIC),(NASDAQ:SGEN),(NYSE:MRK),(NASDAQ:IMGN) EQNX::TICKER_END

News Image
2 months ago - CTI BioPharma Corp.

CTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit

/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will participate in a fireside chat at the JMP Securities Hematology and...

News Image
3 months ago - CTI BioPharma Corp.

CTI BioPharma to Present at Upcoming November Conferences

/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at two upcoming investor conferences in...

News Image
3 months ago - CTI BioPharma Corp.

CTI BioPharma Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the third quarter ended September 30, 2022....

News Image
3 months ago - CTI BioPharma Corp.

CTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022

/PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its third quarter 2022 financial results on...

News Image
4 months ago - The Motley Fool

Why CTI BioPharma Stock Crushed the Market Today

Simultaneous double thumbs-ups from a pair of pundits gave it boost.

News Image
4 months ago - CTI BioPharma Corp.

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...

News Image
4 months ago - The Motley Fool

Why CTI BioPharma Stock Withered on Wednesday

Investors didn't exactly cheer the latest prognosticator move on the company's shares.

News Image
4 months ago - Market News Video

CTI BioPharma (CTIC) Shares Cross Below 200 DMA